<DOC>
	<DOCNO>NCT01901367</DOCNO>
	<brief_summary>This randomize pilot phase II trial study well nutritional intervention exercise intervention work prevent metabolic syndrome young patient acute lymphoblastic leukemia . Nutritional intervention may help weight loss improve quality life patient acute lymphoblastic leukemia . Exercise may help decrease feeling tire caused cancer , may help improve strength , may help build lose muscle tissue . Nutritional intervention plus exercise intervention may effective prevent metabolic syndrome .</brief_summary>
	<brief_title>ALL-Active : A Family-Based Lifestyle Program Pediatric Acute Leukemia Patients</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To evaluate feasibility , adherence , completion rate participant satisfaction associate family base lifestyle intervention overweight pediatric acute lymphoblastic leukemia ( ALL ) patient high risk become ( body mass index [ BMI ] &gt; = 50th percentile ) . II . Assess change BMI z-score , waist circumference , body composition , blood pressure exercise tolerance physical activity baseline , immediately post intervention three month later . III . Assess change serum glucose , insulin , leptin adiponectin patient intervention course 3 month post intervention . IV . Assess change self-reported quality life , physical activity , caloric intake , fatigue associate nutrition exercise program participant primary caregiver . OUTLINE : Patients randomize 1 2 arm . ARM I : Patients receive standard care individualize diet exercise plan monthly booster follow-up session nutritionist exercise physiologist weekly phone counsel trained health coach address barrier improve plan adherence . ARM II : Patients receive standard care individualize diet exercise plan . After completion study treatment , patient follow 3 6 month .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>Diagnosis preB cell T cell ALL continuous first remission ; least 3 month maintenance therapy least 7 month remain therapy completion English speaking patient primary caregiver BMI &gt; = 75th percentile time study enrollment ; ( patient &gt; = 75th percentile select group preliminary data high risk become overweight maintenance therapy ) Provision inform consent primary caregiver Any physical mental limitation would prevent participation study activity ( Including limit grade 4 neuropathy inability ambulate ) As intend familybased intervention , family member invite participate , include live one household , however endpoint assess formally patient identify primary caregiver ; sibling require participation .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Adiponectin , Glucose , Insulin , Leptin</keyword>
</DOC>